Usual Interstitial Pneumonia

December 5, 2017December 5, 2017

Veracyte Says Study Backs Up Usefulness of Envisia Genomic Classifier as IPF Diagnostic Tool

Veracyte says new data confirming the analytical validity of its Envisia Genomic Classifier demonstrate its benefits in diagnosing idiopathic pulmonary fibrosis (IPF). The study, “Analytical performance of Envisia: a genomic classifier for ... Read more

November 17, 2017November 17, 2017

Veracyte’s Genomic Tool Aids in Diagnosing IPF Without Surgery, Real-world Data Suggests

Idiopathic Pulmonary Fibrosis

Veracyte presented early data from a real-world clinical test showing that its Envisia Genomic Classifier is an efficient tool for diagnosing idiopathic pulmonary fibrosis (IPF) without invasive and expensive surgery. ... Read more

July 6, 2017July 6, 2017

Study Supports the Development of Envisia Genomic Classifier for IPF Diagnosis

Idiopathic Pulmonary Fibrosis, News

Veracyte recently announced that results from a study supporting the development of the Envisia Genomic Classifier, a genomic test used to improve the diagnosis of idiopathic pulmonary fibrosis (IPF), have been ... Read more

May 28, 2015November 5, 2015

Differences in Collagen Microstructure May Determine Treatment Response in Fibrotic Lung Diseases

Idiopathic Pulmonary Fibrosis, News

In a new study entitled “Second harmonic generation microscopy reveals altered collagen microstructure in usual interstitial pneumonia versus healthy lung,” the authors investigated differences in the structure of human lung tissues ... Read more